In this Issue
MEDICAL EDITOR’S PAGE
By Peter McAllister, MD
New Guidance for Stroke, Opioids and RLS, 10,000th Enrollee in Parkinson's Outcomes Project, Lower Risk of Ischemic Stroke with Rivaroxaban, Sublingual Riluzole Bioequivalence, Clinical Headache Trials
LETTER TO THE EDITOR
By Ira R. Casson, MD; and David C. Viano, Dr. med, PhD
Response From Author By Randolph W. Evans, MD
By Daniel Kantor, MD, FAAN, FANA
The key to building wealth during today’s bull markets, bear markets, and corrections.
By Jason M. O’Dell, MS, CWM; and Robert Peelman, CFP
COVER FOCUS: HEADACHE TREATMENT
A new treatment for managing migraine in the clinic is on the horizon.
By Simy K. Parikh, MD; and Stephen D. Silberstein, MD
Stigma leads to loss of status and diminished quality of life.
By William B. Young, MD, FAHS, FAAN
Ten Questions for Andrew M. Blumenfeld, MD
Understanding trigger perception can improve management.
By Dana P. Turner, MSPH, PhD; Ivana Jchtay, BS;
Adriana D. Lebowitz, BA; Lisa R. Leffert, MD;
and Timothy T. Houle, PhD
External alteration of nerve activity can be effective in treating headache.
By Stewart J. Tepper, MD, FAHS; and Deborah E. Tepper, MD, FAHS
Will CGRP do for prevention what triptans have for acute treatment?
By Robert P. Cowan, MD, FAAN
Questions and answers from Nina Tsakadze, MD, PhD; Natasha Antonovich; PharmD; and Fabian Rossi, MD
FEATURE ARTICLES: PHYSICIAN WELLNESS
Exploring the thin line between building trust and fostering false hope.
By Heidi Mandel, PhD, DPM, LMSW; Steven Mandel, MD; and William Russell Grace, MD
Preventing burnout improves quality of life for neurologists and patients.